Apogee Therapeutics Inc (APGE)
NASDAQ
Fin d'année 31 Décembre 2023 | 2023 |
---|---|
USD (US$) | |
Return on Assets (%) | -41.846 |
Return on Equity (%) | -44.213 |
Return on Invested Capital (%) | -49.012 |
Operating Margin (%) | N/A |
Net Profit Margin (%) | N/A |
Book Value Per Share | 7.497 |
Earnings Per Share | -1.657 |
Cash Per Share | 2.335 |
Working Capital Per Share | 7.457 |
Operating Profit Per Share | N/A |
EBIT Per Share | -1.657 |
EBITDA Per Share | -1.657 |
Free Cash Flow Per Share | -1.654 |
Fin d'année 31 Décembre 2023 | 2023 |
---|---|
Current Ratio | N/A |
Quick Ratio | N/A |
Inventory Turnover (Days) | N/A |
Actions en circulation | N/A |
Fin d'année 31 Décembre 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|
USD (US$) | |||||
Actions en circulation | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,75B |
Ratio cours/bénéfice | -33,21 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 23,58 |
Ratio prix/valeur comptable | 7,34 |
Rendement de dividende | - |
Actions en circulation | 58,51M |
Volume moyen (1 semaine) | 514,79k |
Volume moyen (1 mois) | 618,32k |
Variation sur 52 semaines | 99,71% |
Plus haut sur 52 semaines | 72,29 |
Plus bas sur 52 semaines | 23,7125 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales